Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes

Circulation: Cardiovascular Interventions

Volumn 4, Issue 4, 2011, Pages 349-354

  Umeda, Hisashi ^a   Kawai, Tomoko ^b   Misumida, Naoki ^a   Ota, Tomoyuki ^a   Hayashi, Kazutaka ^a   Iwase, Mitsunori ^a   Izawa, Hideo ^b   Sugino, Shigeo ^a   Shimizu, Takeshi ^c   Takeichi, Yasushi ^a   Ishiki, Ryoji ^a   Inagaki, Haruo ^a   Ozaki, Yukio ^b   Murohara, Toyoaki ^d  

^a TOYOTA MEMORIAL HOSPITAL   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c Aichi Prefectural Cardiovascular and Respiratory Center   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioplasty; Coronary disease; Follow up studies; Restenosis; Stents

Indexed keywords

CYPHER; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGRAPHY; CARDIOVASCULAR DISEASE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVASCULARIZATION; REVIEW; STENT FRACTURE; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RISK FACTORS; SIROLIMUS; TREATMENT OUTCOME;

EID: 81855225687     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.110.958306     Document Type: Review

References (23)

1. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, Douglas J, Lambert C, Mooney M, Yakubov S, Kuntz RE; SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 2004;110:3773-3780. (Pubitemid 40023975)
2. Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW. Five-year follow-up after sirolimus-eluting stent implantation: results of the SIRIUS trial. J Am Coll Cardiol. 2009;53:1488-1497.
3. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. Five-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol. 2009;54:894-902.
4. Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008;358: 342-352. (Pubitemid 351159233)
5. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, Onuma Y, Higashikuni Y, Otsuki S, Yagishita A, Yachi S, Nakajima H, Hara K. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007; 69:380-386. (Pubitemid 46339279)
6. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv. 2007;69:387-394. (Pubitemid 46339280)
7. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, Shim BS. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol. 2007;100:627-630. (Pubitemid 47223137)
8. Okumura M, Ozaki Y, Ishii J, Kan S, Naruse H, Matsui S, Ishikawa M, Hattori K, Gochi T, Nakano T, Yamada A, Kato S, Motoyama S, Sarai M, Takagi Y, Ismail TF, Nomura M, Hishida H. Restenosis and stent fracture following sirolimus-eluting stent implantation: a serial quantitative coronary angiography and intravascular ultrasound study. Circ J. 2007; 71:1669-1677. (Pubitemid 350240084)
9. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, Inagaki H, Toyama J, Yokota M, Murohara T. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol. 2009;133:321-326.
10. Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ, Simonton CA, Garg J, Lokhnygina Y, Mancini GB, Yeoh E, Buller CE; ACROSS/TOSCA-4 Investigators. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions. J Am Coll Cardiol Intv. 2009;2:97-106.
11. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, Takarada S, Kitabata H, Tanimoto T, Mizukoshi M, Imanishi T, Akasaka T. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J. 2009;73:2036-2041.
12. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009;103: 923-929.
13. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery. J Am Coll Cardiol. 2009;54: 1924-1931.
14. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J. 2007;356:1020-1029. (Pubitemid 46376802)
15. Carter AJ. Drug-eluting stent fracture. J Am Coll Cardiol. 2009;54: 1932-1934.
16. Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, Serruys PW. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv. 2004;61:111-116. (Pubitemid 38036800)
17. Hamilos MI, Papafaklis MI, Ligthart JM, Serruys PW, Sianos G. Stent fracture and restenosis of a paclitaxel-eluting stent. Hellenic J Cardiol. 2005;46:439-442. (Pubitemid 43116734)
18. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009-1019. (Pubitemid 46376801)
19. Daemen J, Kukreja N, van Twisk PH, Onuma Y, de Jaegere PP, van Domburg R, Serruys PW. Four-year clinical follow-up of the rapamycineluting stent evaluated at Rotterdam Cardiology Hospital registry. Am J Cardiol. 2008;101:1105-1111.
20. Wilczynska J, Rdzanek A, Kochman J, Horszczaruk GJ, Pietrasik A, Opolski G. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery. Int J Cardiol. 2007;118:126-127. (Pubitemid 46517694)
21. Wu MC, Cheng CC, Huang TY. Fracture of zotarolimus-eluting stent after implantation. Tex Heart Inst J. 2009;36:618-620.
22. Kawai T, Umeda H, Ota M, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Naruse H, Matsui S, Ishii J, Hishida H, Ozaki Y. Do drug elution components increase the risk of fracture of sirolimus-eluting stents? Coron Artery Dis. 2010;21:298-303.
23. Smaldone C, Bacà M, Niccoli G. A case of early drug-eluting stent fracture. J Invasive Cardiol. 2010;22:E186-E188.